News

Public uninformed about cancer therapies, survey suggests


 

Cancer patient

receiving chemotherapy

Photo by Rhoda Baer

Results of a new survey suggest many adults in the UK may be uninformed about cancer treatment options, despite broad media coverage of these therapies.

Personalized drug treatment, immunotherapy, and proton beam therapy have all been covered by the lay media and featured in news stories across the globe.

But a survey of more than 2000 UK adults showed that most respondents were not aware of these treatment types.

Only 19% of respondents said they had heard about immunotherapy, 29% had heard of personalized drug treatment, and 30% had heard of proton beam therapy.

The survey, which included 2081 adults, was conducted online by YouGov in June. It was commissioned by Cancer Research UK and other members of the Radiotherapy Awareness Programme.

The primary goal of the survey was to examine public awareness of radiotherapy. And the results showed that many respondents were unaware of newer, more targeted radiotherapy options.

Respondents were largely uninformed about other types of cancer treatment as well. However, of the respondents who elected to give their opinion (n=1877), most said the National Health Service (NHS) should fund chemotherapy and other drug treatments over radiotherapy.

Survey questions and responses were as follows.

Radiotherapy

Before taking this survey, which, if any, of the following types of radiotherapy had you heard of?

Intensity-modulated radiotherapy 4%
Stereotactic radiotherapy/

stereotactic ablative radiotherapy

3%
Image-guided radiotherapy 9%
Proton beam therapy 30%
Brachytherapy 5%
Radiofrequency ablation 7%
Cyberknife 4%
Gammaknife 6%
Higgs-boson radiotherapy

(red herring option)

6%
Carbon ion radiotherapy

(red herring option)

3%
None of these 50%
Prefer not to say 11%

Other cancer treatments

Which, if any, of the following specific types of cancer treatments/tests had you heard of before taking this survey?

Immunotherapy 19%
Personalized drugs 29%
Monoclonal antibodies 5%
High-dose chemotherapy

with stem cell transplant

26%
Tablet chemotherapy 28%
Molecular diagnostic tests 6%
Robotically assisted surgery/Da Vinci robot 12%
Laparoscopic (keyhole) surgery 39%
None of these 32%
Prefer not to say 11%

NHS funding

What level of priority do you think the NHS should give to funding each of the following 4 types of cancer treatments?

Treatment 1st priority 2nd priority 3rd priority Lowest priority
Chemotherapy &

other drug treatments

57% 29% 10% 4%
Surgery 29% 35% 31% 5%
Radiotherapy 9% 32% 53% 5%
Alternative treatments 5% 4% 6% 86%

Recommended Reading

Outcomes worse with secondary and therapy-related AML compared with de novo AML
MDedge Hematology and Oncology
Persistent mutations linked to poorer outcomes in AML
MDedge Hematology and Oncology
Team quantifies CAM use among seniors with cancer
MDedge Hematology and Oncology
Discovery reveals potential for viral cancer treatment
MDedge Hematology and Oncology
Inhibitors can target CML stem cells
MDedge Hematology and Oncology
Retinoids, FAK inhibitors may aid TKIs in treating ALL subtype
MDedge Hematology and Oncology
Persistent mutations tied to relapse, death in AML
MDedge Hematology and Oncology
BET inhibitor appears to cause memory loss in mice
MDedge Hematology and Oncology
Pathway appears key to fighting adenovirus
MDedge Hematology and Oncology
T-cell finding may have broad implications
MDedge Hematology and Oncology